TrinityPoint Wealth LLC decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 78.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 8,128 shares of the biopharmaceutical company’s stock after selling 29,722 shares during the quarter. TrinityPoint Wealth LLC’s holdings in […]